These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19803732)

  • 1. Aerosol gemcitabine: preclinical safety and in vivo antitumor activity in osteosarcoma-bearing dogs.
    Rodriguez CO; Crabbs TA; Wilson DW; Cannan VA; Skorupski KA; Gordon N; Koshkina N; Kleinerman E; Anderson PM
    J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):197-206. PubMed ID: 19803732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine.
    Gordon N; Kleinerman ES
    J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):189-96. PubMed ID: 20528149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corruption of the Fas pathway delays the pulmonary clearance of murine osteosarcoma cells, enhances their metastatic potential, and reduces the effect of aerosol gemcitabine.
    Gordon N; Koshkina NV; Jia SF; Khanna C; Mendoza A; Worth LL; Kleinerman ES
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4503-10. PubMed ID: 17671136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases.
    Koshkina NV; Kleinerman ES
    Int J Cancer; 2005 Sep; 116(3):458-63. PubMed ID: 15800950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation of the Fas/FasL signaling pathway and the lung microenvironment in the development of osteosarcoma lung metastases.
    Huang G; Nishimoto K; Yang Y; Kleinerman ES
    Adv Exp Med Biol; 2014; 804():203-17. PubMed ID: 24924176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Fas/FasL in the metastatic potential of osteosarcoma and targeting this pathway for the treatment of osteosarcoma lung metastases.
    Gordon N; Kleinerman ES
    Cancer Treat Res; 2009; 152():497-508. PubMed ID: 20213411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.
    Koshkina N; Yang Y; Kleinerman ES
    Adv Exp Med Biol; 2020; 1258():177-187. PubMed ID: 32767242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication of osteosarcoma lung metastasis using intranasal gemcitabine.
    Jia SF; Worth LL; Turan M; Duan Xp XP; Kleinerman ES
    Anticancer Drugs; 2002 Feb; 13(2):155-61. PubMed ID: 11901308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.
    Koshkina NV; Kleinerman ES; Waidrep C; Jia SF; Worth LL; Gilbert BE; Knight V
    Clin Cancer Res; 2000 Jul; 6(7):2876-80. PubMed ID: 10914737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using canine osteosarcoma as a model to assess efficacy of novel therapies: can old dogs teach us new tricks?
    Rodriguez CO
    Adv Exp Med Biol; 2014; 804():237-56. PubMed ID: 24924178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine inhibits viability, growth, and metastasis of osteosarcoma cell lines.
    Ando T; Ichikawa J; Okamoto A; Tasaka K; Nakao A; Hamada Y
    J Orthop Res; 2005 Jul; 23(4):964-9. PubMed ID: 16023013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?
    Xu J; Guo W; Xie L
    BMC Cancer; 2018 Oct; 18(1):987. PubMed ID: 30326879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy in osteosarcoma.
    O'Farrill JS; Gordon N
    Adv Exp Med Biol; 2014; 804():147-60. PubMed ID: 24924173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemcitabine for the treatment of patients with osteosarcoma.
    Wei MY; Zhuang YF; Wang WM
    Asian Pac J Cancer Prev; 2014; 15(17):7159-62. PubMed ID: 25227807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro.
    McMahon MB; Bear MD; Kulp SK; Pennell ML; London CA
    Am J Vet Res; 2010 Jul; 71(7):799-808. PubMed ID: 20594083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing.
    Siena L; Pace E; Ferraro M; Di Sano C; Melis M; Profita M; Spatafora M; Gjomarkaj M
    Immunology; 2014 Feb; 141(2):242-55. PubMed ID: 24128051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS).
    Martin-Broto J; Redondo A; Valverde C; Vaz MA; Mora J; Garcia Del Muro X; Gutierrez A; Tous C; Carnero A; Marcilla D; Carranza A; Sancho P; Martinez-Trufero J; Diaz-Beveridge R; Cruz J; Encinas V; Taron M; Moura DS; Luna P; Hindi N; Lopez-Pousa A
    Ann Oncol; 2017 Dec; 28(12):2994-2999. PubMed ID: 29045512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosolized Chemotherapy for Osteosarcoma.
    Gordon N; Felix K; Daw NC
    Adv Exp Med Biol; 2020; 1257():67-73. PubMed ID: 32483731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced anticancer effect of gemcitabine by genistein in osteosarcoma: the role of Akt and nuclear factor-kappaB.
    Zhang B; Shi ZL; Liu B; Yan XB; Feng J; Tao HM
    Anticancer Drugs; 2010 Mar; 21(3):288-96. PubMed ID: 20038829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local release of gemcitabine via in situ UV-crosslinked lipid-strengthened hydrogel for inhibiting osteosarcoma.
    Wu W; Dai Y; Liu H; Cheng R; Ni Q; Ye T; Cui W
    Drug Deliv; 2018 Nov; 25(1):1642-1651. PubMed ID: 30799654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.